Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
February 19th, 2025
Aroa Biosurgery Narrowly Misses Full-Year Guidance
Read More
February 18th, 2025
Immuron Sales Up 70% in First Half
Read More
February 18th, 2025
Leading the Way – Adalta's East to West Roadmap
Read More
February 17th, 2025
Opthea's Phase 3 Results Fast Approaching
Read More
January 28th, 2025
Wheels in Motion for Cogstate
Read More
January 9th, 2025
Dimerix Secures Third Licensing Deal
Read More
December 22nd, 2024
Anteris Completes Re-Domiciliation to US, Raises US$88 Million, Maintains Australian Listing
Read More
Pages
1
